| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.32 | 0.04 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |